PUBLIC SAFETY CONCERNS ARISING FROM UNKNOWN MECHANISMS: LEGAL FRAMEWORK AND JUDICIAL ANALYSIS

1. INTRODUCTION

Unknown mechanisms create significant public safety concerns in biotechnology, medical devices, pharmaceuticals, artificial intelligence-assisted healthcare, and other emerging technologies. The term refers to situations in which the underlying biological, chemical, technical, or operational processes of a product or intervention are not sufficiently understood to predict its effects, identify potential hazards, or establish reliable safety limits.

In biotechnology, an intervention may produce unexpected biological responses, unintended interactions, delayed adverse effects, or unpredictable consequences. Where the mechanism of action is insufficiently established, researchers, manufacturers, healthcare institutions, and regulatory authorities may face difficulties assessing risks before public use.

The principal legal concern is that scientific uncertainty must not become an excuse for inadequate safety testing, incomplete disclosure, or the avoidance of responsibility. Public safety requires precaution, transparency, independent assessment, and continuing monitoring.

2. MAJOR PUBLIC SAFETY CONCERNS

A. UNPREDICTABLE BIOLOGICAL EFFECTS

An incompletely understood mechanism may produce unexpected physiological or biological effects. A treatment may affect pathways beyond its intended purpose, creating potential risks to patients and, in certain circumstances, wider populations.

B. INSUFFICIENT RISK ASSESSMENT

Where the mechanism is unknown, conventional testing may not identify every relevant hazard. Inadequate investigation can result in premature clinical use or commercial distribution.

C. UNEXPECTED LONG-TERM CONSEQUENCES

Some adverse effects may emerge only after prolonged exposure or repeated use. Insufficient knowledge of the mechanism makes it difficult to establish reliable predictions concerning delayed toxicity, immune responses, or other complications.

D. INADEQUATE INFORMED CONSENT

Patients and research participants may not understand the scientific uncertainty associated with an intervention. Failure to communicate material uncertainties can undermine informed consent and individual autonomy.

E. ENVIRONMENTAL AND POPULATION RISKS

Where biotechnology involves environmental exposure or biological release, an insufficient understanding of the mechanism may complicate ecological risk assessment, containment decisions, and long-term monitoring.

F. REGULATORY AND ACCOUNTABILITY GAPS

Uncertainty can create difficulties in determining whether a product satisfies established safety standards. Manufacturers and institutions must not present unverified assumptions as established scientific facts.

3. LEGAL AND REGULATORY FRAMEWORK IN INDIA

1. Constitution of India – Article 21: Protects life and personal liberty. Public authorities must take appropriate measures against serious and foreseeable threats to human life.

2. Environment (Protection) Act, 1986: Provides a framework for preventing environmental harm and regulating hazardous activities. Its provisions are relevant where uncertain biological or technological interventions create environmental risks.

3. Consumer Protection Act, 2019: Provides remedies for defective products, deficient services, misleading representations, and product-related injuries. Sections 82–87 specifically address product liability.

4. Drugs and Cosmetics Act, 1940: Establishes regulatory controls concerning the manufacture, distribution, and sale of drugs to protect public health.

5. Medical Devices Rules, 2017: Establish requirements for the regulation and quality control of medical devices, including applicable licensing and safety obligations.

6. Biological Diversity Act, 2002: Provides a framework for conservation, sustainable use, and regulation of access to biological resources, as applicable.

7. Cartagena Protocol on Biosafety: Establishes an international framework for biosafety considerations relating to living modified organisms and potential environmental risks.

4. IMPORTANT JUDICIAL DECISIONS

1. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle and the polluter-pays principle as important components of environmental law. This is relevant where scientific uncertainty creates potential environmental dangers.

2. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court discussed scientific uncertainty, environmental decision-making, and the importance of expert scientific assessment. It is particularly relevant where the consequences of an activity are not fully understood.

3. Indian Council for Enviro-Legal Action v. Union of India (1996)

The Supreme Court emphasised accountability for environmental damage and the responsibility of industries causing pollution. Its principles are relevant to potentially hazardous technological activities.

4. M.C. Mehta v. Union of India (Oleum Gas Leak Case) (1987)

The Supreme Court developed the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities. This is important when technological uncertainty accompanies hazardous industrial operations.

5. Samira Kohli v. Dr. Prabha Manchanda (2008)

The Supreme Court explained the requirements of valid informed consent. The judgment is relevant where patients must be informed about material risks and uncertainties associated with experimental or unfamiliar medical interventions.

6. Jacob Mathew v. State of Punjab (2005)

The Supreme Court clarified the standards governing criminal medical negligence. Professionals must exercise appropriate care and competence, although an adverse outcome or scientific uncertainty alone does not establish criminal negligence.

7. A.P. Pollution Control Board v. Prof. M.V. Nayudu (2001)

The Court further considered the importance of scientific expertise in environmental adjudication. It supports the need for informed regulatory decisions when the scientific basis of potential hazards remains uncertain.

5. RESPONSIBILITIES OF MANUFACTURERS, RESEARCHERS AND INSTITUTIONS

Manufacturers must conduct appropriate safety assessments, disclose known limitations, maintain reliable documentation, and avoid unsupported safety claims. Researchers must obtain ethical approval, communicate material uncertainties, and comply with applicable research safeguards.

Healthcare institutions must ensure appropriate clinical supervision, informed consent, adverse-event reporting, and post-treatment monitoring. Regulatory authorities should require evidence proportionate to the potential severity of harm and the degree of uncertainty.

6. PREVENTIVE AND COMPLIANCE MEASURES

Conduct independent scientific and safety assessments before public use.

Establish transparent documentation of known and unknown effects.

Apply precautionary safeguards where credible risks are identified.

Obtain valid informed consent for experimental interventions.

Introduce continuing safety and adverse-event monitoring.

Establish reporting, investigation, and corrective-action procedures.

Restrict or suspend unsafe applications where legally justified.

Maintain independent ethical and regulatory oversight.

7. CONCLUSION

Unknown mechanisms present serious public safety challenges because incomplete scientific understanding may prevent accurate prediction of adverse effects. Indian constitutional, environmental, consumer-protection, pharmaceutical, and medical-device laws provide important safeguards against risks arising from uncertain technologies. Decisions such as Vellore Citizens' Welfare Forum, A.P. Pollution Control Board v. Nayudu, M.C. Mehta, and Samira Kohli demonstrate the importance of precaution, scientific expertise, accountability, and informed consent. Ultimately, scientific uncertainty requires stronger scrutiny, transparent disclosure, proportionate restrictions, and continuous monitoring rather than automatic acceptance of potentially hazardous technologies.